Approvals/TGA/DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial

Approved

STANDARD

DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c488d7d4bc239f44
Product Name: DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial
Artg Id: 455605
Artg Name: DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2025-03-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

c488d7d4bc239f44

Type

Standard